FDA warns of cybersecurity risk with certain Medtronic insulin pumps
2022-09-20
Financial Post

The information displayed in the AIM should not be reported as representing the official views of the OECD or of its member countries.
The FDA has warned that Medtronic's MiniMed 600 Series insulin pumps, which use AI to manage insulin delivery, are vulnerable to cyberattacks. Hackers could potentially alter insulin dosing by accessing the device during wireless pairing, posing a direct health risk, though no incidents have been reported yet.[AI generated]